Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Azacitidine With Carboplatin and Paclitaxel for Newly Diagnosed Ovarian Cancer

This study has been withdrawn prior to enrollment.
(No enrollment. Unable to recruit due to lack of eligible patients.)
Sponsor:
Collaborator:
Celgene Corporation
Information provided by (Responsible Party):
Loyola University
ClinicalTrials.gov Identifier:
NCT00842582
First received: February 11, 2009
Last updated: November 1, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: March 2011
  Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)